-
1
-
-
80052270947
-
The epidemiology of renal cell carcinoma
-
Ljungberg B, Campbell SC, Choi HY et al. The epidemiology of renal cell carcinoma. Eur. Urol. 60(4), 615-621 (2011).
-
(2011)
Eur. Urol.
, vol.60
, Issue.4
, pp. 615-621
-
-
Ljungberg, B.1
Campbell, S.C.2
Choi, H.Y.3
-
2
-
-
77955493600
-
EAU guidelines on renal cell carcinoma: The 2010 update
-
Ljungberg B, Cowan NC, Hanbury DC et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur. Urol. 58(3), 398-406 (2010).
-
(2010)
Eur. Urol.
, vol.58
, Issue.3
, pp. 398-406
-
-
Ljungberg, B.1
Cowan, N.C.2
Hanbury, D.C.3
-
3
-
-
78049484272
-
Integrating surgery with targeted therapies for renal cell carcinoma: Current evidence and ongoing trials
-
Bex A, Jonasch E, Kirkali Z et al. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur. Urol. 58(6), 819-828 (2010).
-
(2010)
Eur. Urol.
, vol.58
, Issue.6
, pp. 819-828
-
-
Bex, A.1
Jonasch, E.2
Kirkali, Z.3
-
4
-
-
6344243850
-
-
IARC Press, Lyon, France
-
Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, France (2004).
-
(2004)
Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs
-
-
Eble, J.N.1
Sauter, G.2
Epstein, J.I.3
Sesterhenn, I.A.4
-
5
-
-
77952545672
-
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
-
Szymanska K, Moore LE, Rothman N et al. TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe. Cancer Lett. 293(1), 92-98 (2010).
-
(2010)
Cancer Lett.
, vol.293
, Issue.1
, pp. 92-98
-
-
Szymanska, K.1
Moore, L.E.2
Rothman, N.3
-
6
-
-
80052263465
-
ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of metastatic disease
-
Patard JJ, Pignot G, Escudier B et al. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease. Eur. Urol. 60(4), 684-690 (2011).
-
(2011)
Eur. Urol.
, vol.60
, Issue.4
, pp. 684-690
-
-
Patard, J.J.1
Pignot, G.2
Escudier, B.3
-
7
-
-
33846681333
-
Modern therapeutic approaches in metastatic renal cell carcinoma
-
Staehler M, Haseke N, Schoeppler G, Stadler T, Gratzke C, Stief CG. Modern therapeutic approaches in metastatic renal cell carcinoma. EAU-EBU Update Series 5(1), 26-37 (2007).
-
(2007)
EAU-EBU Update Series
, vol.5
, Issue.1
, pp. 26-37
-
-
Staehler, M.1
Haseke, N.2
Schoeppler, G.3
Stadler, T.4
Gratzke, C.5
Stief, C.G.6
-
8
-
-
79651472671
-
MicroRNAs and their target gene networks in renal cell carcinoma
-
Redova M, Svoboda M, Slaby O. MicroRNAs and their target gene networks in renal cell carcinoma. Biochem. Biophys. Res. Commun. 405(2), 153-156 (2011).
-
(2011)
Biochem. Biophys. Res. Commun.
, vol.405
, Issue.2
, pp. 153-156
-
-
Redova, M.1
Svoboda, M.2
Slaby, O.3
-
9
-
-
84877938018
-
Von Hippel-Lindau syndrome
-
Chou A, Toon C, Pickett J, Gill AJ. von Hippel-Lindau syndrome. Front. Horm. Res. 41, 30-49 (2013).
-
(2013)
Front. Horm. Res.
, vol.41
, pp. 30-49
-
-
Chou, A.1
Toon, C.2
Pickett, J.3
Gill, A.J.4
-
10
-
-
4644363095
-
The von Hippel-Lindau tumor suppressor gene and kidney cancer
-
Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin. Cancer Res. 10(18 Pt 2), 6290S-6295S (2004).
-
(2004)
Clin. Cancer Res.
, vol.10
, Issue.18 PART 2
-
-
Kaelin Jr., W.G.1
-
11
-
-
0035835819
-
The von Hippel-Lindau tumor suppressor gene
-
Kondo K, Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene. Exp. Cell. Res. 264(1), 117-125 (2001).
-
(2001)
Exp. Cell. Res.
, vol.264
, Issue.1
, pp. 117-125
-
-
Kondo, K.1
Kaelin Jr., W.G.2
-
12
-
-
0037326037
-
The von Hippel-Lindau tumor suppressor hypoxia-inducible factor-1 (HIF-1) degradation and cancer pathogenesis
-
Pugh CW, Ratcliffe PJ. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 13(1), 83-89 (2003).
-
(2003)
Semin. Cancer Biol.
, vol.13
, Issue.1
, pp. 83-89
-
-
Pugh, C.W.1
Ratcliffe, P.J.2
-
13
-
-
50849090006
-
Von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1
-
Lee SJ, Lattouf JB, Xanthopoulos J, Linehan WM, Bottaro DP, Vasselli JR. von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1. Eur. Urol. 54(4), 845-853 (2008).
-
(2008)
Eur. Urol.
, vol.54
, Issue.4
, pp. 845-853
-
-
Lee, S.J.1
Lattouf, J.B.2
Xanthopoulos, J.3
Linehan, W.M.4
Bottaro, D.P.5
Vasselli, J.R.6
-
14
-
-
84897038587
-
-
Lippincott Williams & Wilkins, PA, USA
-
Devita VTL, Theodore S, Rosenberg, Steven A. Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology. Lippincott Williams & Wilkins, PA, USA, 4-8 (2008).
-
(2008)
Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology.
, pp. 4-8
-
-
Vtl, D.1
Theodore, S.2
Rosenberg Steven, A.3
-
15
-
-
65349117540
-
Clinical implications of hypoxia inducible factor in renal cell carcinoma
-
Smaldone MC, Maranchie JK. Clinical implications of hypoxia inducible factor in renal cell carcinoma. Urol. Oncol. 27(3), 238-245 (2009).
-
(2009)
Urol. Oncol.
, vol.27
, Issue.3
, pp. 238-245
-
-
Smaldone, M.C.1
Maranchie, J.K.2
-
16
-
-
46749122616
-
Prognostic factors for renall cell carcinoma
-
Furniss D, Harden P, Ali N et al. Prognostic factors for renall cell carcinoma. Cancer Treat. Rev. 34, 407-426 (2008).
-
(2008)
Cancer Treat. Rev.
, vol.34
, pp. 407-426
-
-
Furniss, D.1
Harden, P.2
Ali, N.3
-
17
-
-
20444485232
-
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2 driven VHL-/-renal cancer
-
Smith K, Gunaratnam L, Morley M. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2 driven VHL-/-renal cancer. Cancer Res. 65(12), 5221-5230 (2005).
-
(2005)
Cancer Res.
, vol.65
, Issue.12
, pp. 5221-5230
-
-
Smith, K.1
Gunaratnam, L.2
Morley, M.3
-
18
-
-
74549114727
-
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
-
Mitsudomi T, Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 277, 301-308 (2009).
-
(2009)
FEBS J.
, vol.277
, pp. 301-308
-
-
Mitsudomi, T.1
Yatabe, Y.2
-
20
-
-
84891484340
-
Drug delivery and drug resistance: EGFR-tyrosine kinase inhibitors in non-small cell lung cancer
-
Olcay E, Giovannetti E, Peters G. Drug delivery and drug resistance: EGFR-tyrosine kinase inhibitors in non-small cell lung cancer. Open Lung Cancer J. 3, 26-33 (2010).
-
(2010)
Open Lung Cancer J.
, vol.3
, pp. 26-33
-
-
Olcay, E.1
Giovannetti, E.2
Peters, G.3
-
21
-
-
11244319884
-
A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter
-
Liu W, Innocenti F, Wu M et al. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res. 65(1), 46-53 (2005).
-
(2005)
Cancer Res.
, vol.65
, Issue.1
, pp. 46-53
-
-
Liu, W.1
Innocenti, F.2
Wu, M.3
-
22
-
-
1842471336
-
Signaling through the epidermal growth factor receptor during the development of malignancy
-
Grandis J, Sok J. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol. Ther. 102, 37-46 (2004).
-
(2004)
Pharmacol. Ther.
, vol.102
, pp. 37-46
-
-
Grandis, J.1
Sok, J.2
-
23
-
-
80052854931
-
The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR
-
Zhou L, Yang H. The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR. PLoS ONE 6(9), e23936 (2011).
-
(2011)
PLoS ONE
, vol.6
, Issue.9
-
-
Zhou, L.1
Yang, H.2
-
24
-
-
61949090107
-
Regulation of endocytosis via the oxygen-sensing pathway
-
Wang Y, Roche O, Yan MS et al. Regulation of endocytosis via the oxygen-sensing pathway. Nat. Med. 15(3), 319-324 (2009).
-
(2009)
Nat. Med.
, vol.15
, Issue.3
, pp. 319-324
-
-
Wang, Y.1
Roche, O.2
Yan, M.S.3
-
25
-
-
84878108145
-
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
-
Shen J, Xia W, Khotskaya YB et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497(7449), 383-387 (2013).
-
(2013)
Nature
, vol.497
, Issue.7449
, pp. 383-387
-
-
Shen, J.1
Xia, W.2
Khotskaya, Y.B.3
-
26
-
-
45849094041
-
Update on the medical treatment of metastatic renal cell carcinoma
-
Ravaud A, Wallerand H, Culine S et al. Update on the medical treatment of metastatic renal cell carcinoma. Eur. Urol. 54(2), 315-325 (2008).
-
(2008)
Eur. Urol.
, vol.54
, Issue.2
, pp. 315-325
-
-
Ravaud, A.1
Wallerand, H.2
Culine, S.3
-
27
-
-
50649099256
-
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma
-
Rini BI, Flaherty K. Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma. Urol. Oncol. 26(5), 543-549 (2008).
-
(2008)
Urol. Oncol.
, vol.26
, Issue.5
, pp. 543-549
-
-
Rini, B.I.1
Flaherty, K.2
-
28
-
-
84867143840
-
Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma
-
Ravaud A, Gross-Goupil M. Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma. Cancer Treat. Rev. 38(8), 996-1003 (2012).
-
(2012)
Cancer Treat. Rev.
, vol.38
, Issue.8
, pp. 996-1003
-
-
Ravaud, A.1
Gross-Goupil, M.2
-
29
-
-
80054691489
-
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development
-
Gambari R, Fabbri E, Borgatti M et al. Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem. Pharmacol. 82(10), 1416-1429 (2011).
-
(2011)
Biochem. Pharmacol.
, vol.82
, Issue.10
, pp. 1416-1429
-
-
Gambari, R.1
Fabbri, E.2
Borgatti, M.3
-
30
-
-
84859652376
-
Secretory miRNAs as novel cancer biomarkers
-
Zhang J, Zhao H, Gao Y, Zhang W. Secretory miRNAs as novel cancer biomarkers. Biochim. Biophys. Acta 1826(1), 32-43 (2012).
-
(2012)
Biochim. Biophys. Acta
, vol.1826
, Issue.1
, pp. 32-43
-
-
Zhang, J.1
Zhao, H.2
Gao, Y.3
Zhang, W.4
-
31
-
-
84869866890
-
MicroRNA and cancer
-
Jansson MD, Lund AH. MicroRNA and cancer. Mol. Oncol. 6(6), 590-610 (2012).
-
(2012)
Mol. Oncol.
, vol.6
, Issue.6
, pp. 590-610
-
-
Jansson, M.D.1
Lund, A.H.2
-
32
-
-
84869887497
-
DNA methylation and microRNA dysregulation in cancer
-
Suzuki H, Maruyama R, Yamamoto E, Kai M. DNA methylation and microRNA dysregulation in cancer. Mol. Oncol. 6(6), 567-578 (2012).
-
(2012)
Mol. Oncol.
, vol.6
, Issue.6
, pp. 567-578
-
-
Suzuki, H.1
Maruyama, R.2
Yamamoto, E.3
Kai, M.4
-
33
-
-
84874722125
-
Delivering the promise of miRNA cancer therapeutics
-
Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. Delivering the promise of miRNA cancer therapeutics. Drug Discov. Today 18(5-6), 282-289 (2013).
-
(2013)
Drug Discov. Today
, vol.18
, Issue.5-6
, pp. 282-289
-
-
Pereira, D.M.1
Rodrigues, P.M.2
Borralho, P.M.3
Rodrigues, C.M.4
-
34
-
-
41149098674
-
MicroRNA biogenesis, functionality and cancer relevance
-
Kusenda B, Mraz M, Mayer J, Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 150(2), 205-215 (2006).
-
(2006)
Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub.
, vol.150
, Issue.2
, pp. 205-215
-
-
Kusenda, B.1
Mraz, M.2
Mayer, J.3
Pospisilova, S.4
-
35
-
-
79953249325
-
MicroRNA in prostate, bladder, and kidney cancer: A systematic review
-
Catto JW, Alcaraz A, Bjartell AS et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 59(5), 671-681 (2011).
-
(2011)
Eur. Urol.
, vol.59
, Issue.5
, pp. 671-681
-
-
Catto, J.W.1
Alcaraz, A.2
Bjartell, A.S.3
-
36
-
-
72649084669
-
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis
-
Chow TF, Youssef YM, Lianidou E et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin. Biochem. 43(1-2), 150-158 (2010).
-
(2010)
Clin. Biochem.
, vol.43
, Issue.1-2
, pp. 150-158
-
-
Chow, T.F.1
Youssef, Y.M.2
Lianidou, E.3
-
37
-
-
84881163733
-
Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: A study in a southern European population
-
Marques I, Teixeira AL, Ferreira M et al. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population. Mol. Biol. Rep. 40(8), 4819-4826 (2013).
-
(2013)
Mol. Biol. Rep.
, vol.40
, Issue.8
, pp. 4819-4826
-
-
Marques, I.1
Teixeira, A.L.2
Ferreira, M.3
-
38
-
-
77954386364
-
MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
-
Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 42(8), 1273-1281 (2010).
-
(2010)
Int. J. Biochem. Cell Biol.
, vol.42
, Issue.8
, pp. 1273-1281
-
-
Cho, W.C.1
-
39
-
-
84871092992
-
The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared with the proximal tubular epithelial cells of the kidney
-
Duns G, van den Berg A, van Dijk MC et al. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared with the proximal tubular epithelial cells of the kidney. Genes Chromosomes Cancer 52(2), 165-173 (2012).
-
(2012)
Genes Chromosomes Cancer
, vol.52
, Issue.2
, pp. 165-173
-
-
Duns, G.1
Van Den Berg, A.2
Van Dijk, M.C.3
-
40
-
-
84879890360
-
Comprehensive molecular characterization of clear cell renal cell carcinoma
-
Cancer Genome Atlas Research Network.
-
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499(7456), 43-49 (2013).
-
(2013)
Nature
, vol.499
, Issue.7456
, pp. 43-49
-
-
-
41
-
-
84870654513
-
MiR-21 downregulated TCF21 to inhibit KISS1 in renal cancer
-
Zhang H, Guo Y, Shang C, Song Y, Wu B. miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. Urology 80(6), 1298-1302 (2012).
-
(2012)
Urology
, vol.80
, Issue.6
, pp. 1298-1302
-
-
Zhang, H.1
Guo, Y.2
Shang, C.3
Song, Y.4
Wu, B.5
-
42
-
-
36649025655
-
OncomiRs: The discovery and progress of microRNAs in cancers
-
Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 6, 60 (2007).
-
(2007)
Mol. Cancer
, vol.6
, pp. 60
-
-
Cho, W.C.1
-
43
-
-
77956339881
-
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
-
Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467(7311), 86-90 (2010).
-
(2010)
Nature
, vol.467
, Issue.7311
, pp. 86-90
-
-
Medina, P.P.1
Nolde, M.2
Slack, F.J.3
-
44
-
-
80053923978
-
Prognostic role of microRNA-21 in various carcinomas: A systematic review and meta-analysis
-
Fu X, Han Y, Wu Y et al. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur. J. Clin. Invest. 41(11), 1245-1253 (2011).
-
(2011)
Eur. J. Clin. Invest.
, vol.41
, Issue.11
, pp. 1245-1253
-
-
Fu, X.1
Han, Y.2
Wu, Y.3
-
45
-
-
78650385772
-
MicroRNA-21: A novel therapeutic target in human cancer
-
Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol. Ther. 10(12), 1224-1232 (2010).
-
(2010)
Cancer Biol. Ther.
, vol.10
, Issue.12
, pp. 1224-1232
-
-
Pan, X.1
Wang, Z.X.2
Wang, R.3
-
46
-
-
79955534639
-
MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1a expression
-
Liu LZ, Li C, Chen Q et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1a expression. PLoS ONE 6(4), e19139 (2011).
-
(2011)
PLoS ONE
, vol.6
, Issue.4
-
-
Liu, L.Z.1
Li, C.2
Chen, Q.3
-
47
-
-
75949106927
-
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
-
Zhou X, Ren Y, Moore L et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab. Invest. 90(2), 144-155 (2010).
-
(2010)
Lab. Invest.
, vol.90
, Issue.2
, pp. 144-155
-
-
Zhou, X.1
Ren, Y.2
Moore, L.3
-
48
-
-
80053597754
-
MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia
-
Bruning U, Cerone L, Neufeld Z et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 31(19), 4087-4096 (2011).
-
(2011)
Mol. Cell. Biol.
, vol.31
, Issue.19
, pp. 4087-4096
-
-
Bruning, U.1
Cerone, L.2
Neufeld, Z.3
-
49
-
-
84877621093
-
MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma
-
Shinmei S, Sakamoto N, Goto K et al. MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma. Int. J. Urol. 20(5), 468-477 (2013).
-
(2013)
Int. J. Urol.
, vol.20
, Issue.5
, pp. 468-477
-
-
Shinmei, S.1
Sakamoto, N.2
Goto, K.3
-
50
-
-
77950300363
-
Identification of a microRNA panel for clear-cell kidney cancer
-
Juan D, Alexe G, Antes T et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 75(4), 835-841 (2010).
-
(2010)
Urology
, vol.75
, Issue.4
, pp. 835-841
-
-
Juan, D.1
Alexe, G.2
Antes, T.3
-
51
-
-
84862026516
-
Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma
-
Valera VA, Walter BA, Linehan WM, Merino MJ. Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma. J. Cancer 2, 515-526 (2011).
-
(2011)
J. Cancer
, vol.2
, pp. 515-526
-
-
Valera, V.A.1
Walter, B.A.2
Linehan, W.M.3
Merino, M.J.4
-
52
-
-
77953483108
-
MicroRNA-210: A unique and pleiotropic hypoxamir
-
Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9(6), 1072-1083 (2010).
-
(2010)
Cell Cycle
, vol.9
, Issue.6
, pp. 1072-1083
-
-
Chan, S.Y.1
Loscalzo, J.2
-
53
-
-
84870929798
-
Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
-
Zhao A, Li G, Peoc'h M, Genin C, Gigante M. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp. Mol. Pathol. 94(1), 115-120 (2013).
-
(2013)
Exp. Mol. Pathol.
, vol.94
, Issue.1
, pp. 115-120
-
-
Zhao, A.1
Li, G.2
Peoc'H, M.3
Genin, C.4
Gigante, M.5
-
54
-
-
84861940940
-
High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
-
Zhang C, Zhang J, Hao J et al. High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J. Transl. Med. 10(1), 119 (2012).
-
(2012)
J. Transl. Med.
, vol.10
, Issue.1
, pp. 119
-
-
Zhang, C.1
Zhang, J.2
Hao, J.3
-
55
-
-
70949104622
-
MiR-221 and 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
-
Garofalo M, Di Leva G, Romano G et al. miR-221 and 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16(6), 498-509 (2009).
-
(2009)
Cancer Cell
, vol.16
, Issue.6
, pp. 498-509
-
-
Garofalo, M.1
Di Leva, G.2
Romano, G.3
-
56
-
-
80053576554
-
MicroRNAs miR-221 and miR-222: A new level of regulation in aggressive breast cancer
-
Shah M, Calin G. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med. 3(8), 56 (2011).
-
(2011)
Genome Med.
, vol.3
, Issue.8
, pp. 56
-
-
Shah, M.1
Calin, G.2
-
57
-
-
84876072586
-
EGFR signaling pathway and related-miRNAs in age-related diseases: The example of miR-221 and miR-222
-
Teixeira AL, Gomes M, Medeiros R. EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222. Front. Genet. 3(286), 7 (2012).
-
(2012)
Front. Genet.
, vol.3
, Issue.286
, pp. 7
-
-
Teixeira, A.L.1
Gomes, M.2
Medeiros, R.3
-
58
-
-
80053586899
-
MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels
-
Wulfken LM, Moritz R, Ohlmann C et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS ONE 6(9), e25787 (2011).
-
(2011)
PLoS ONE
, vol.6
, Issue.9
-
-
Wulfken, L.M.1
Moritz, R.2
Ohlmann, C.3
-
59
-
-
0033954247
-
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha
-
Ravi R, Mookerjee B, Bhujwalla ZM et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14(1), 34-44 (2000).
-
(2000)
Genes Dev.
, vol.14
, Issue.1
, pp. 34-44
-
-
Ravi, R.1
Mookerjee, B.2
Bhujwalla, Z.M.3
-
60
-
-
77956294987
-
Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents
-
Lou JJ, Chua YL, Chew EH, Gao J, Bushell M, Hagen T. Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents. PLoS ONE 5(5), e10522 (2010).
-
(2010)
PLoS ONE
, vol.5
, Issue.5
-
-
Lou, J.J.1
Chua, Y.L.2
Chew, E.H.3
Gao, J.4
Bushell, M.5
Hagen, T.6
-
61
-
-
84858712300
-
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
-
Redova M, Poprach A, Nekvindova J et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J. Transl. Med. 10, 55 (2012).
-
(2012)
J. Transl. Med.
, vol.10
, pp. 55
-
-
Redova, M.1
Poprach, A.2
Nekvindova, J.3
-
62
-
-
84897102977
-
Circulating microRNA-222 in plasma -A potencial biomarker for renal cell carcinoma
-
Teixeira AL, Silva J, Ferreira M et al. Circulating microRNA-222 in plasma -a potencial biomarker for renal cell carcinoma. Eur. J. Cancer 48(Suppl. 5), S216 (2012).
-
(2012)
Eur. J. Cancer
, vol.48
, Issue.5 SUPPL.
-
-
Teixeira, A.L.1
Silva, J.2
Ferreira, M.3
-
63
-
-
84880273186
-
Potential biofluid markers and treatment targets for renal cell carcinoma
-
Wettersten HI, Weiss RH. Potential biofluid markers and treatment targets for renal cell carcinoma. Nat. Rev. Urol. 10(6), 336-344 (2013).
-
(2013)
Nat. Rev. Urol.
, vol.10
, Issue.6
, pp. 336-344
-
-
Wettersten, H.I.1
Weiss, R.H.2
-
64
-
-
70350755290
-
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
-
Jung M, Mollenkopf HJ, Grimm C et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J. Cell. Mol. Med. 13(9B), 3918-3928 (2009).
-
(2009)
J. Cell. Mol. Med.
, vol.13
, Issue.9 B
, pp. 3918-3928
-
-
Jung, M.1
Mollenkopf, H.J.2
Grimm, C.3
-
65
-
-
79957773360
-
Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis
-
Koturbash I, Zemp FJ, Pogribny I, Kovalchuk O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutat. Res. 722(2), 94-105 (2011).
-
(2011)
Mutat. Res.
, vol.722
, Issue.2
, pp. 94-105
-
-
Koturbash, I.1
Zemp, F.J.2
Pogribny, I.3
Kovalchuk, O.4
-
66
-
-
79953234117
-
Accurate molecular classification of kidney cancer subtypes using microRNA signature
-
Youssef YM, White NM, Grigull J et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur. Urol. 59(5), 721-730 (2011).
-
(2011)
Eur. Urol.
, vol.59
, Issue.5
, pp. 721-730
-
-
Youssef, Y.M.1
White, N.M.2
Grigull, J.3
-
67
-
-
79651469908
-
Role of miR-10b in breast cancer metastasis
-
Ma L. Role of miR-10b in breast cancer metastasis. Breast Cancer Res. 12(5), 26 (2010).
-
(2010)
Breast Cancer Res.
, vol.12
, Issue.5
, pp. 26
-
-
Ma, L.1
-
68
-
-
84255192032
-
MiR-221 silencing blocks hepatocellular carcinoma and promotes survival
-
Park JK, Kogure T, Nuovo GJ et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 71(24), 7608-7616 (2011).
-
(2011)
Cancer Res.
, vol.71
, Issue.24
, pp. 7608-7616
-
-
Park, J.K.1
Kogure, T.2
Nuovo, G.J.3
-
69
-
-
66449136951
-
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
-
Kota J, Chivukula RR, O'Donnell KA et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137(6), 1005-1017 (2009).
-
(2009)
Cell
, vol.137
, Issue.6
, pp. 1005-1017
-
-
Kota, J.1
Chivukula, R.R.2
O'Donnell, K.A.3
-
70
-
-
84885472168
-
-
Accessed 1 March 2013
-
GeneCards®. www.genecards.org (Accessed 1 March 2013)
-
GeneCards®.
-
-
|